GE HealthCare Technologies (GEHC) Net Income towards Common Stockholders (2022 - 2026)
GE HealthCare Technologies (GEHC) reported Net Income towards Common Stockholders of $411.0 million for Q1 2026, down 30.1% on a YoY basis from $588.0 million in Q1 2025, and down 31.73% quarter-over-quarter from $602.0 million in Q4 2025.
GE HealthCare Technologies (GEHC) Net Income towards Common Stockholders (2022 - 2026) Analysis & Trends
GE HealthCare Technologies has reported Net Income towards Common Stockholders for 5 years, with the latest figure at $411.0 million in Q1 2026.
- For the quarter ending Q1 2026, Net Income towards Common Stockholders fell 30.1% year-over-year to $411.0 million; the trailing twelve-month figure through Mar 2026 stood at $2.0 billion (down 10.42% YoY), and the FY2025 full-year result was $2.1 billion, up 4.57% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at $411.0 million, down from $602.0 million in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was $721.0 million in Q4 2024, with the low at $189.0 million in Q1 2023.
- Historically, Net Income towards Common Stockholders has averaged $462.2 million across 5 years, with a median of $464.0 million in 2025.
- Annual changes were most pronounced in 2023 — Net Income towards Common Stockholders tumbled 51.41% — and 2024, when it soared 97.88%.
- GE HealthCare Technologies' Net Income towards Common Stockholders stood at $554.0 million in 2022, then fell by 27.26% to $403.0 million in 2023, then jumped by 78.91% to $721.0 million in 2024, then decreased by 16.5% to $602.0 million in 2025, then slumped by 31.73% to $411.0 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at $411.0 million (Q1 2026), $602.0 million (Q4 2025), and $464.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 187,319.30 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | 238.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 411.00 Mn |
| Dec 31, 2025 | 602.00 Mn |
| Sep 30, 2025 | 464.00 Mn |
| Jun 30, 2025 | 500.00 Mn |
| Mar 31, 2025 | 588.00 Mn |
| Dec 31, 2024 | 721.00 Mn |
| Sep 30, 2024 | 470.00 Mn |
| Jun 30, 2024 | 428.00 Mn |
| Mar 31, 2024 | 374.00 Mn |
| Dec 31, 2023 | 403.00 Mn |
| Sep 30, 2023 | 375.00 Mn |
| Jun 30, 2023 | 418.00 Mn |
| Mar 31, 2023 | 189.00 Mn |
| Dec 31, 2022 | 554.00 Mn |
| Sep 30, 2022 | 487.00 Mn |
| Jun 30, 2022 | 485.00 Mn |
| Mar 31, 2022 | 389.00 Mn |